Compounds > quinazolines
Page last updated: 2024-08-21

quinazolines and Acneiform Eruptions

quinazolines has been researched along with Acneiform Eruptions in 31 studies

Research

Studies (31)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's18 (58.06)29.6817
2010's13 (41.94)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Irifune, K; Ito, R; Miyawaki, S; Sayama, K; Tohyama, M1
Megahed, M; Wahl, RU1
Kishi, A; Kiyohara, Y; Yamazaki, N1
Chang, JC; Osborne, CK; Parma, J; Pavlick, A; Rimawi, M; Schiff, R; Trivedi, MV1
Chiu, HC; Chiu, HY1
Duncan, WC; Horne, AW; Johns, TG; Neil, P; Skubisz, MM; Tong, S; Wallace, EM1
Chen, KL; Cho, YT; Chu, CY; Lin, CC; Sheen, YS; Tsai, HE; Yang, CW1
Bianchi, F; Neri, I; Patrizi, A1
Brown, CW; Campbell, TM1
Barletta, E; Cusano, F; Ferrara, G; Ingordo, V1
Alkemade, JA; Bovenschen, HJ1
Dirschka, T; Hauschild, A; Kroth, J; Wollenberg, A1
Domínguez-Fernández, I; Eguren, C; García-Díez, A; Santiago-Sánchez-Mateos, DI1
Muro, Y; Shimoyama, Y; Sugiura, K; Tomita, Y; Yamaki, M1
Llombart, B; Requena, C; Sanmartín, O1
Cho, BC; Lee, JH; Park, JH; Shin, JU1
Wang, B; Wang, YN; Zhao, Q1
Giaccone, G; Kirtschig, G; Scheffer, E; Stoof, TJ; Van Doorn, R1
España, A; Fernandez-Galar, M; López-Picazo, JM1
Choi, JH; Kim, SW; Koh, JK; Lee, HW; Lee, MW; Moon, KC; Seo, CW; Yang, HJ1
Bessis, D; Fabbro, M; Guillot, B; Jacot, W; Jorda, E; Pujol, JL; Ychou, M1
Treudler, R; Zouboulis, CC1
Journagan, S; Obadiah, J1
Acebo, E; Díaz-Pérez, JL; Lasa, O; Martínez de Lagrán, Z; Ratón, JA1
Bartralot, R; Bodet, D; García-Patos, V; Heras, C; Mollet, J1
Sipples, R1
Koldenhof, JJ; Sigurdsson, V; Tjin-A-ton, ML; van Montfrans, C; Voest, EE; Witteveen, PO1
Basti, S; Jampol, LM; Zhang, G1
Nguyen, D; Parr, AL; Steinberg, SM; Tan, AR; Yang, SX1
Schalock, PC; Zug, KA1
Cruz Hernández, JJ; Delgado Fernández, C; Mezquita Pérez, L; Navarro Martín, M; Rodríguez Sánchez, C1

Reviews

3 review(s) available for quinazolines and Acneiform Eruptions

ArticleYear
Erlotinib-related skin toxicities: treatment strategies in patients with metastatic non-small cell lung cancer.
    Journal of the American Academy of Dermatology, 2013, Volume: 69, Issue:3

    Topics: Acneiform Eruptions; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Eruptions; Erlotinib Hydrochloride; Humans; Ichthyosis; Lung Neoplasms; Paronychia; Patient Education as Topic; Pruritus; Quinazolines

2013
[Cutaneous side effects of EGFR inhibitors--appearance and management].
    Deutsche medizinische Wochenschrift (1946), 2010, Volume: 135, Issue:4

    Topics: Acneiform Eruptions; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cetuximab; Drug Eruptions; ErbB Receptors; Erlotinib Hydrochloride; Gefitinib; Hair Diseases; Humans; Ichthyosis; Mucositis; Neoplasms; Panitumumab; Paronychia; Protein Kinase Inhibitors; Quinazolines

2010
Common side effects of anti-EGFR therapy: acneform rash.
    Seminars in oncology nursing, 2006, Volume: 22, Issue:1 Suppl 1

    Topics: Acneiform Eruptions; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cetuximab; Diarrhea; Drug Eruptions; ErbB Receptors; Erlotinib Hydrochloride; Gefitinib; Humans; Neoplasms; Nurse's Role; Oncology Nursing; Patient Education as Topic; Quinazolines; Severity of Illness Index

2006

Trials

2 trial(s) available for quinazolines and Acneiform Eruptions

ArticleYear
Development of acneiform rash does not predict response to lapatinib treatment in patients with breast cancer.
    Pharmacotherapy, 2013, Volume: 33, Issue:10

    Topics: Acneiform Eruptions; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Drug Eruptions; Female; Humans; Lapatinib; Middle Aged; Neoadjuvant Therapy; Prospective Studies; Quinazolines; Receptor, ErbB-2; Treatment Outcome

2013
Markers in the epidermal growth factor receptor pathway and skin toxicity during erlotinib treatment.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:1

    Topics: Acneiform Eruptions; Antineoplastic Agents; Biomarkers; Biopsy; Breast Neoplasms; Carcinoma; Drug Eruptions; ErbB Receptors; Erlotinib Hydrochloride; Folliculitis; Gene Expression Profiling; Humans; Ki-67 Antigen; Mitogen-Activated Protein Kinases; Neoplasm Proteins; Phosphorylation; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; Skin

2008

Other Studies

26 other study(ies) available for quinazolines and Acneiform Eruptions

ArticleYear
Pressure sore-like ulcers on acneiform papules caused by EGFR inhibitors.
    International wound journal, 2014, Volume: 11, Issue:5

    Topics: Acneiform Eruptions; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Female; Gefitinib; Humans; Japan; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Pressure Ulcer; Quinazolines; Wound Healing

2014
[Erlotinib-induced acneiform eruption].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2013, Volume: 64, Issue:5

    Topics: Acneiform Eruptions; Adenocarcinoma; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Ciprofloxacin; Doxycycline; Drug Therapy, Combination; Erlotinib Hydrochloride; Fluoroquinolones; Humans; Lung Neoplasms; Male; Methylprednisolone; Quinazolines; Quinolizines; Treatment Outcome

2013
Scalp pustules in a patient receiving chemotherapy.
    JAMA, 2013, Sep-11, Volume: 310, Issue:10

    Topics: Acneiform Eruptions; Aged; Aged, 80 and over; Biopsy; Drug Eruptions; ErbB Receptors; Erlotinib Hydrochloride; Gefitinib; Humans; Lung Neoplasms; Male; Quinazolines; Scalp

2013
Combination gefitinib and methotrexate treatment for non-tubal ectopic pregnancies: a case series.
    Human reproduction (Oxford, England), 2014, Volume: 29, Issue:7

    Topics: Abortifacient Agents, Nonsteroidal; Acneiform Eruptions; Adult; Cesarean Section; Chorionic Gonadotropin; Fallopian Tubes; Female; Gefitinib; Humans; Methotrexate; Pregnancy; Pregnancy Outcome; Pregnancy, Ectopic; Quinazolines; Ultrasonography, Prenatal; Young Adult

2014
Comparison of Skin Toxic Effects Associated With Gefitinib, Erlotinib, or Afatinib Treatment for Non-Small Cell Lung Cancer.
    JAMA dermatology, 2016, Volume: 152, Issue:3

    Topics: Acneiform Eruptions; Afatinib; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Compassionate Use Trials; Cross-Sectional Studies; Drug Eruptions; Erlotinib Hydrochloride; Gefitinib; Humans; Ichthyosis; Lung Neoplasms; Paronychia; Pruritus; Quinazolines; Retrospective Studies

2016
Rosaceiform eruption induced by erlotinib.
    Dermatologic therapy, 2008, Volume: 21 Suppl 2

    Topics: Acneiform Eruptions; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Drug Eruptions; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Male; Protein Kinase Inhibitors; Quinazolines

2008
Dimorphic cutaneous manifestation of a toxic eruption due to erlotinib therapy.
    Journal of drugs in dermatology : JDD, 2008, Volume: 7, Issue:12

    Topics: Acneiform Eruptions; Aged; Drug Eruptions; Erlotinib Hydrochloride; Folliculitis; Humans; Male; Protein Kinase Inhibitors; Psoriasis; Quinazolines

2008
Erlotinib-induced pustular eruption.
    Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2009, Volume: 144, Issue:1

    Topics: Acneiform Eruptions; Administration, Cutaneous; Anti-Bacterial Agents; Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Erythromycin; Gels; Humans; Lung Neoplasms; Male; Middle Aged; Protein Kinase Inhibitors; Quinazolines; Treatment Outcome

2009
Erlotinib-induced dermatologic side-effects.
    International journal of dermatology, 2009, Volume: 48, Issue:3

    Topics: Acneiform Eruptions; Aged; Antineoplastic Agents; Chickenpox; Drug Eruptions; Epidermal Growth Factor; Erlotinib Hydrochloride; Female; Herpesvirus 3, Human; Humans; Protein Kinase Inhibitors; Quinazolines; Virus Activation

2009
[Erlotinib-induced acneiform rash not affecting previously irradiated skin].
    Actas dermo-sifiliograficas, 2010, Volume: 101, Issue:2

    Topics: Acneiform Eruptions; Antineoplastic Agents; Arm; Carcinoma, Squamous Cell; Combined Modality Therapy; ErbB Receptors; Erlotinib Hydrochloride; Facial Dermatoses; Humans; Laryngeal Neoplasms; Laryngectomy; Male; Middle Aged; Neck Dissection; Neoplasm Proteins; Organ Specificity; Protein Kinase Inhibitors; Quinazolines; Radiotherapy, Adjuvant; Skin; Thorax

2010
Epidermal growth factor receptor tyrosine kinase inhibitors induce CCL2 and CCL5 via reduction in IL-1R2 in keratinocytes.
    Experimental dermatology, 2010, Volume: 19, Issue:8

    Topics: Acneiform Eruptions; Adolescent; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Case-Control Studies; Cell Line; Enzyme Inhibitors; ErbB Receptors; Female; Gefitinib; Humans; Interleukin-1; Keratinocytes; Lung Neoplasms; Male; Middle Aged; Quinazolines; Receptors, Interleukin-1; Receptors, Interleukin-1 Type II; RNA, Messenger; Signal Transduction

2010
Acneiform eruptions induced by epidermal growth factor receptor inhibitors: treatment with oral isotretinoin.
    Cutis, 2012, Volume: 90, Issue:2

    Topics: Acneiform Eruptions; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cetuximab; Dermatologic Agents; Drug Eruptions; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Isotretinoin; Male; Quinazolines

2012
Treatment of epidermal growth factor receptor inhibitor-induced acneiform eruption with topical recombinant human epidermal growth factor.
    Dermatology (Basel, Switzerland), 2012, Volume: 225, Issue:2

    Topics: Acneiform Eruptions; Antineoplastic Agents; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Drug Eruptions; Epidermal Growth Factor; ErbB Receptors; Gefitinib; Humans; Lung Neoplasms; Male; Middle Aged; Quinazolines; Treatment Outcome; Tumor Cells, Cultured

2012
Spared pre-irradiated area in pustular lesions induced by icotinib showing decreased expressions of CD1a+ langerhans cells and FGFR2.
    Japanese journal of clinical oncology, 2013, Volume: 43, Issue:2

    Topics: Acneiform Eruptions; Adenocarcinoma; Adenocarcinoma of Lung; Antigens, CD1; Antineoplastic Agents; Biopsy; Blister; Chemotherapy, Adjuvant; Crown Ethers; Dose Fractionation, Radiation; Down-Regulation; Drug Eruptions; Enzyme Inhibitors; ErbB Receptors; Face; Folliculitis; Humans; Immunohistochemistry; Ki-67 Antigen; Langerhans Cells; Lung Neoplasms; Male; Middle Aged; Protein-Tyrosine Kinases; Quinazolines; Receptor, Fibroblast Growth Factor, Type 2; Skin; Thoracic Wall

2013
Follicular and epidermal alterations in patients treated with ZD1839 (Iressa), an inhibitor of the epidermal growth factor receptor.
    The British journal of dermatology, 2002, Volume: 147, Issue:3

    Topics: Acneiform Eruptions; Antineoplastic Agents; Drug Eruptions; ErbB Receptors; Female; Gefitinib; Humans; Male; Middle Aged; Quinazolines

2002
Acneiform lesions secondary to ZD1839, an inhibitor of the epidermal growth factor receptor.
    Clinical and experimental dermatology, 2004, Volume: 29, Issue:2

    Topics: Acneiform Eruptions; Adenocarcinoma; Antineoplastic Agents; Drug Eruptions; Gefitinib; Humans; Lung Neoplasms; Male; Middle Aged; Quinazolines

2004
Cutaneous side effects in non-small cell lung cancer patients treated with Iressa (ZD1839), an inhibitor of epidermal growth factor.
    Acta dermato-venereologica, 2004, Volume: 84, Issue:1

    Topics: Acneiform Eruptions; Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Enzyme Inhibitors; Epidermal Growth Factor; Female; Gefitinib; Humans; Lung Neoplasms; Male; Middle Aged; Paronychia; Quinazolines; Retrospective Studies; Signal Transduction; Skin; Urticaria

2004
Acneiform eruption induced by epidermal growth factor receptor inhibitors in patients with solid tumours.
    The British journal of dermatology, 2004, Volume: 151, Issue:1

    Topics: Acneiform Eruptions; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cetuximab; Drug Eruptions; ErbB Receptors; Female; Gefitinib; Humans; Male; Middle Aged; Neoplasms; Quinazolines

2004
Follicular drug eruption induced by gefitinib (ZD 1839, iressa): clinical picture correlates with in vitro data of focal epidermal necrosis after epidermal growth factor inhibition in skin cultures.
    Dermatology (Basel, Switzerland), 2005, Volume: 211, Issue:4

    Topics: Acneiform Eruptions; Aged; Antineoplastic Agents; Cells, Cultured; Drug Eruptions; ErbB Receptors; Facial Dermatoses; Fatal Outcome; Gefitinib; Humans; Male; Protein-Tyrosine Kinases; Quinazolines; Skin; Stevens-Johnson Syndrome

2005
An acneiform eruption due to erlotinib: prognostic implications and management.
    Journal of the American Academy of Dermatology, 2006, Volume: 54, Issue:2

    Topics: Acneiform Eruptions; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Lung Neoplasms; Middle Aged; Prognosis; Quinazolines

2006
[Acneiform eruption from epidermal growth factor receptor inhibitors].
    Actas dermo-sifiliograficas, 2005, Volume: 96, Issue:7

    Topics: Acneiform Eruptions; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cetuximab; Drug Eruptions; ErbB Receptors; Erlotinib Hydrochloride; Female; Gefitinib; Humans; Male; Middle Aged; Quinazolines

2005
[Contribution to acneiform eruptions by epidermal growth factor receptor inhibitors].
    Actas dermo-sifiliograficas, 2006, Volume: 97, Issue:2

    Topics: Acneiform Eruptions; Adenocarcinoma; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cetuximab; Colonic Neoplasms; Disease Susceptibility; Drug Eruptions; ErbB Receptors; Gefitinib; Humans; Liver Neoplasms; Lung Neoplasms; Male; Neoplasm Proteins; Quinazolines; Staphylococcal Skin Infections; Superinfection

2006
[Skin eruptions as an adverse reaction to epidermal growth-factor receptor inhibitors].
    Nederlands tijdschrift voor geneeskunde, 2007, Apr-28, Volume: 151, Issue:17

    Topics: Acneiform Eruptions; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Carcinoma; Cetuximab; Drug Eruptions; ErbB Receptors; Gefitinib; Humans; Kidney Neoplasms; Male; Melanoma; Middle Aged; Paronychia; Protein Kinase Inhibitors; Quinazolines

2007
Acquired trichomegaly and symptomatic external ocular changes in patients receiving epidermal growth factor receptor inhibitors: case reports and a review of literature.
    Cornea, 2007, Volume: 26, Issue:7

    Topics: Acneiform Eruptions; Adenocarcinoma, Bronchiolo-Alveolar; Aged, 80 and over; Antineoplastic Agents; Blepharitis; Carcinoma, Small Cell; ErbB Receptors; Erlotinib Hydrochloride; Eyelashes; Female; Gefitinib; Humans; Hypertrichosis; Lung Neoplasms; Middle Aged; Quinazolines; Retrospective Studies

2007
Acneiform reaction to erlotinib.
    Dermatitis : contact, atopic, occupational, drug, 2007, Volume: 18, Issue:4

    Topics: Acneiform Eruptions; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Eruptions; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Male; Middle Aged; Protein Kinase Inhibitors; Quinazolines

2007
[Acneiforme rash in woman with pulmonary adenocarcinoma].
    Revista clinica espanola, 2008, Volume: 208, Issue:5

    Topics: Acneiform Eruptions; Adenocarcinoma; Aged; Drug Eruptions; Erlotinib Hydrochloride; Facial Dermatoses; Female; Humans; Lung Neoplasms; Protein Kinase Inhibitors; Quinazolines

2008